TARA Earnings

Quarterly EPS
$-0.50
Q3 2024
$-0.47
Q4 2024
$-0.29
Q1 2025
$-0.35
Q2 2025
$-0.31
Q3 2025
$-0.38
Q4 2025
$-0.31
Q1 2026
$-0.36
Q2 2026
Latest RevenueN/A
Latest Net Income-21668000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.360-21668000-2.9%
Q1 2026-$0.310-17782000-6.9%
Q4 2025-$0.380-17307000+19.1%
Q3 2025-$0.310-13258000+38.0%
Q2 2025-$0.350-14960000+22.2%
Q1 2025-$0.290-11914000+70.1%
Q4 2024-$0.470-12769000+47.8%
Q3 2024-$0.500-11219000+42.5%
Q2 2024-$0.450-9513000
Q1 2024-$0.970-11095000
Q4 2023-$0.900-10221000
Q3 2023-$0.870-9860000
Protara Therapeutics (TARA) — Earnings